Rationale: Compromised development of blood vessel walls leads to vascular instability that may predispose to aneurysm with risk of rupture and lethal hemorrhage. There is currently a lack of insight into developmental insults that may define the molecular and cellular characteristics of initiating and perpetrating factors in adult aneurismal disease.
T he development of a functional vasculature is an essential process during embryogenesis, perturbations in which result in fetal lethality or vascular disease after birth. The formation of systemic blood vessels occurs in a stereotypical fashion -endothelial tubes form through a number of mechanisms (angiogenesis, vasculogenesis, or intussusception). 1 Endothelial cells then recruit mural cells comprising the subsets of vascular smooth muscle cells (VSMCs) and pericytes to the external wall of the vessel. [2] [3] [4] These mural cells are required to provide structural support for the blood vessel and probably play a role in maintaining endothelial health and integrity. The establishment of a vessel wall is accomplished either through the differentiation of de novo mural cells from precursor populations or recruitment from a proliferating pool of mature cells. The former is thought to occur chiefly through the actions of endothelial secreted transforming growth factor-beta (TGF␤) and the latter through paracrine platelet-derived growth factor-B (PDGF-B). 4 Typically, in the embryo, mural cells originate from the in situ differentiation of mesodermal tissues, which surround endothelial tubes. 3, 5 The exception to this is in the central nervous system, where blood vessels recruit to their outer layer via the migration of neurectodermal-derived mature mural cells, as typified by the development of the postnatal retinal vasculature. 2, 5 Consequences of failed mural cell recruitment range widely, depending on the degree of mural cell coverage. Midgestation lethality is seen in Alk5 knockout mice coinci-dent with a failure to differentiate mural cells. 6 However, mutants with a partial loss of mural cells can survive to later stages. The PDGF receptor-␤-null mouse dies perinatally, probably due to hemorrhage and edema as a result of lack of structural support to blood vessels. 7 In contrast, the endothe-lial-specific PDGF-BB knockout mouse survives into adulthood with reduced mural cell coverage but has deficiencies in renal and cardiac function. 8 Nevertheless, in all of these described mutants, some degree of mural cell contribution to blood vessels is still observed, indicating that additional signals are required for mural cell differentiation from progenitor cells.
Thymosin ␤4 (T␤4) is a 43-amino acid peptide encoded by the gene Tmsb4x on the X chromosome in mouse. It was initially identified as a G-actin-binding protein with the ability to regulate the cellular availability of actin monomers for the formation of polymeric F-actin. 7 In recent times, however, novel functions have been ascribed to T␤4, based on its ability to affect cell behavior when applied extracellularly or in a paracrine fashion. 7 Notably, T␤4 has been shown to improve cardiac function after ischemic injury. 8 -10 These cardioprotective effects may be due in part to the ability of T␤4 to stimulate the differentiation of new coronary vascular cells, including coronary VSMCs, and consequently facilitate the process of neovascularization within the infarcted myocardium. 9 Although several groups have shown that exogenous T␤4 can promote angiogenesis both in vitro and ex vivo, 11, 12 the role T␤4 plays in the systemic vasculature in vivo is unknown. We describe a requirement for endothelial T␤4 in the Figure 1. T␤4 is expressed in the endothelium of the developing aorta. Whole-mount in situ hybridization at E9.5 reveals T␤4 staining in the dorsal aorta (A, white arrowheads). Sagittal (B) and coronal (C) sections at E9.5 confirm the aortic expression of T␤4 (black arrowheads highlight wall of dorsal aorta) (B and C). From E10.5, T␤4 begins to be expressed in the microvasculature (D), notably highlighted by expression in the dermal vascular plexus of the limb bud (E) and the intersomitic vessels (F, white arrowheads). Expression of T␤4 in the developing aorta colocalizes with the endothelial marker endomucin (G) at E10.5, whereas at E12.5 expression was also observed at a relatively lower level in the SM␣Aϩ compartment (H). 
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Methods
An expanded Methods section is available in the Online Data Supplement.
Mouse Lines
Mice were housed and maintained in a controlled environment, and all procedures were performed in accordance with the Animals (Scientific Procedures) Act 1986, (Home Office, United Kingdom). Global T␤4 KO mice were generated by deleting exon 2 of the Tmsb4x locus and maintained on a C57Bl6/J background for more than 20 generations. Endothelial-specific T␤4 knockdown mice were generated by crossing female mice, containing a previously described T␤4 short hairpin RNA (shRNA) 9 targeted to the hypoxanthine phosphoribosyltransferase locus with Tie2-Cre male mice. 13 A cardiac-specific T␤4 shRNA knockdown strain has been previously described, 10 using a Nkx2-5-Cre knock-in 14 crossed with the T␤4 shRNA knockdown strain.
Histology, Immunofluorescence, and In Situ Hybridization
Standard histological, immunohistochemical, immunofluorescence, and in situ hybridization were performed on frozen or paraffin embryo sections or on whole-mount fixed embryos or retinas harvested at postnatal day 6, as described in full in the Online Supplement.
Real-Time PCR
Real-time quantitative PCR (qRT-PCR) was performed according to a standard ⌬⌬CT protocol using SYBR green (Applied Biosystems). Primer sequences are given in the Online Supplement.
Cell Culture
10T1/2 cells and A404 cells were maintained under standard conditions. For stimulation experiments, cells were treated for 4 days with PBS vehicle control, 1 g/mL T␤4, 2 ng/mL TGF␤, or 1 g/mL T␤4 plus 2 ng/mL TGF␤ before RNA extraction using Trizol reagent (Invitrogen). For Smad 2 phosphorylation assays, A404 cells were serum-starved (0.5% fetal calf serum) overnight before stimulation, as above, for 20 minutes before protein extraction and standard Western blotting. For coculture experiments, early-passage human umbilical vein endothelial cells (HUVECs) were cultured in 50:50 A404:HUVEC medium (endothelial cell growth medium, PromoCell) for 24 hours; cells were counted, and an equal number of A404 cells were plated in each well. Thereafter, cells were cocultured in A404 medium for 4 days, with or without the addition of a neutralizing rabbit polyclonal anti-T␤4 antibody (1:250; Immundiagnostik). 10T1/2 cells were transfected with Smad activity luciferase reporter plasmids (SA Biosciences) using Effectene transfection reagent (Qiagen) according to the manufacturer's instructions. After 16 hours, cells were serum-starved overnight (0.5% FCS in DMEMϩGlutamax) before stimulation for 6 hours in the presence of 100 ng/mL T␤4, 2 ng/mL TGF␤, 100 ng/mL T␤4 plus 2 ng/mL TGF␤, or a PBS vehicle control. Smad activity-dependent firefly luciferase activity was measured by dual luciferase reporter assay (Promega). Crossing of T␤4 Ϫ/Y adult male mice with T␤4 ϩ/Ϫ adult females should result in equal proportions of T␤4 ϩ/Y, T␤4 Ϫ/Y, T␤4 ϩ/Ϫ, and T␤4 Ϫ/Ϫ in the F1. At E10.5, mendelian ratios are retained, however, by E14.5 and between E14.5 and birth (postnatal day 1), embryonic lethality has caused a significant number (Pϭ3.01ϫ10 Ϫ4 and Pϭ1.1ϫ10 Ϫ5 , respectively) of T␤4 Ϫ/Y and T␤4 Ϫ/Ϫ to die in utero. Endothelial-specific knockdown of T␤4 by intercrossing Tie2-Cre/ϩ and HPRT-targeted T␤4floxshRNAϩ/Ϫ results in a loss of knockdown embryos between the equivalent stages of E10.5 and 14.5 (Pϭ0.718) and E14.5 and P1 (Pϭ0.073), approaching statistical significance by P1. Embryonic lethality in both models is attributed to systemic vascular hemorrhaging (E10.5 to E14.5) and coronary vessel defects (E14.5 to P1).
Exon Array Analysis
Micro-arrays were performed on Affymetrix Mouse Exon 1.0ST arrays. Raw data were processed with Affymetrix expression console software before being analyzed for gene expression changes in Partek. Statistics were performed in R and pathway analysis performed using the Metacore software (Genego).
Statistics
Statistical analysis was performed with Graphpad Prism software. Contingency tables were analyzed by 2 test. Two-tailed, unpaired, nonparametric t tests were used for all other statistical tests.
Results
T␤4 Is Expressed in the Endothelium of the Developing Embryo
To investigate vascular expression of T␤4 during development, whole-mount and section in situ hybridization was performed on midgestation embryos. T␤4 was expressed in the dorsal aorta of the developing embryo from E9.5 onward ( Figure 1A , 1B, and 1C). At E10.5, T␤4 expression appeared relatively ubiquitous at low resolution ( Figure 1D ) but was detected in all developing blood vessels in the embryo ( Figure 1D through 1F), including those within the developing limb bud ( Figure 1E ) and the intersomitic vessels ( Figure  1F ). Immunofluorescence analysis revealed that T␤4 was predominantly expressed in the developing endothelium at E10.5, which was retained at E12.5. Relatively weaker expression was observed in the mural cell population of the dorsal aorta at E12.5, consistent with the onset of a more differentiated smooth muscle cell layer ( Figure 1G and 1H).
Loss of T␤4 Causes Hemorrhage Due to a Defect in Mural Cell Recruitment to Developing Vessels
To determine whether T␤4 plays an essential role during the development of the systemic vasculature, a global loss of function model of T␤4 was created by replacing exon 2 of the Tmsb4x gene with a neomycin resistance cassette resulting in a functionally null allele (Online Figure I ). Hemizygous null male (T␤4 Ϫ/Y) mice reach adulthood, but in reduced numbers, indicating a degree of embryonic lethality ( Table  1 ). The loss of T␤4 Ϫ/Y embryos was progressive from insignificant lethality before and up to E10.5 (21% versus 25% expected; Pϭ0.482) through to significantly reduced recovery of mutants at E14.5 (16% versus 25% expected; Pϭ3.01ϫ10 Ϫ4 ) and up to birth (17% versus 25% expected; Pϭ1.01ϫ10 Ϫ5 ), indicating incomplete penetrance (Table 1) . When E10.5 T␤4 Ϫ/Y embryos were examined, it was apparent that approximately 10% of T␤4 Ϫ/Y embryos displayed abnormal accumulation of blood in their hearts (Figure 2A and 2B). Mutant embryos also revealed extensive cranial bleeding in the midbrain region compared with ϩ/Y controls ( Figure 2C and 2D) and in axial sections there was clear evidence of both pericardial and coelomic cavity hemorrhage ( Figure 2E through 2H). Severe vascular hemorrhaging at E10.5 was incompatible with continued survival accounting for the significant loss of T␤4 Ϫ/Y mutant between E10.5 and E14.5 ( Table 1 ). Over the course of the studies, we observed a reduction in embryonic lethality, reflecting an overall increase from approximately 60% to 80% survival of T␤4 Ϫ/Y mutant mice to postnatal stages. This was coincident with a reduced incidence of the more severe hemorrhagic phenotype identified at E10.5, down from 44% to 20%, and reflected in an increased recovery of viable embryos at E14.5. The data in Table 1 represent current embryonic lethality versus survival rates against expected mendelian ratios.
Such hemorrhagic phenotypes can arise through defective mural cell investiture of developing blood vessels. 15, 16 Thus, T␤4 Ϫ/Y embryos were examined for mural cell defects. Immunofluorescence studies for NG2, a marker that we initially confirmed as specific for mural cells and excluded from the developing endothelium ( Figure 3A and 3B), showed that by E10.5 wild-type embryos displayed a dorsal aorta invested with NG2-positive mural cells ( Figure 3C ). This mural cell coverage was significantly reduced in T␤4 Ϫ/Y embryos (consistent with the hemorrhagic phenotype observed in Figure 2H ) in comparison to littermate T␤4 ϩ/Y controls ( Figure 3C through 3F). The mural cell coverage directly correlated with severity of phenotype, observed in Figure 4C and 4D), suggested that the endothelial cell contacts were intact across all genotypes, including both in mildly and severely affected mutants relative to T␤4 ϩ/Y controls ( Figure 4E through 4G). This was supported by immunostaining for zona occludens 1 (ZO-1) ( Figure 4H through 4N ), a marker of To confirm that the mural cell defects observed in T␤4 Ϫ/Y embryos were due to a deficiency of T␤4 in the endothelium, as suggested by the expression data ( Figure 1 ), rather than a lack of T␤4 acting cell autonomously in mural cells, we made use of a mouse strain that enables transcription of a T␤4 shRNA under the control of Cre recombinase with the potential for tissue-specific knockdown of T␤4. 9 By crossing this mouse with a Tie2-Cre strain, 13 knockdown of T␤4 specifically in the developing endothelium was achieved ( Figure 5 ). Initially, we observed a gross hemorrhagic phenotype (including cranial, pericardial, and coelomic cavity bleeding) in 30% of the endothelial-specific T␤4-knockdown embryos at E10.5 (nϭ24 embryos analyzed), which was equivalent to the one-third documented for the global T␤4 Ϫ/Y mutants. In addition, we recorded an overall incidence of embryonic lethality in Tie2-Cre T␤4 shRNA animals of 12% (animals lost in utero between E10.5 and E14.5 and up to P1 according to expected mendelian ratios at birth) compared with 17% for the Ϫ/Y knockout animals ( Table 1 ). The reduced incidence of loss in utero in the EC specific T␤4-shRNA model may reflect both inefficient knockdown via the Cre/shRNA as demonstrated by qRT-PCR ( Figure 5 ) and additional developmental roles for T␤4 highlighted by global loss of function, such as an essential requirement in epicardial-derived coronary vasculogenesis. 9 The latter was confirmed as a contributory factor to the differential embry-onic lethality between E14.5 and P1 by analyzing the coronary vasculature of T␤4 Ϫ/Y embryos at E14.5 (Online Figure III ). We observed a significant incidence of VSMCs abnormally residing within the epicardial layer and reduced presence in the underlying myocardium, compared with T␤4 ϩ/Y littermate controls (Online Figure IIIA and B) , a phenotype consistent with that described after myocardial shRNA knockdown of T␤4. 9 Serial sections through the developing dorsal aorta of Tie2-Cre T␤4 shRNA embryos revealed defective NG2positive mural cell recruitment to the vessel wall in comparison to Cre-only littermate controls ( Figure 5A and 5B). The defective recruitment was equivalent to that observed after global knockdown of T␤4 ( Figure 3C through 3E ). Knockdown of T␤4 expression in Tie2-Cre T␤4 shRNA embryos was confirmed by qRT-PCR on isolated dorsal aortas ( Figure  5C ) and protein knockdown via immunostaining for T␤4 with Image J quantification (Online Figure IV) ; abrogation of T␤4 mRNA and protein expression was incomplete at approximately 40% of control levels in each case (Figure, 5C; Online Figure IVI ). Mural cell density around the wall of the aorta was quantitatively assessed by cell counts across serial sections, which revealed a significant reduction in mural cell coverage after endothelial-specific knockdown of T␤4 (Figure 5D ). Finally, as for the global knockout model, we assessed VE-cadherin expression by immunofluorescence to reveal that the endothelium was intact in Tie2-Cre T␤4 shRNA aortas ( Figure 5E and 5F). Collectively, these data reveal a non-cell autonomous role for endothelial T␤4 in 
Endothelial T␤4 Stimulates Differentiation of Mesodermal Cells to a Mature Mural Cell Phenotype
Mural cell defects in developmental mutants have previously been attributed to either aberrant migration, survival, proliferation, or differentiation of mural cells. 2 The postnatal retinal vasculature, consistent with its status as a central nervous system tissue, derives a mural cell layer via the migration of phenotypically mature mural cells along the developing vascular plexus. Whereas T␤4 is expressed in the primary plexus vasculature of the early postnatal (P6) retina (Online Figure VA and B) , P6 retinas from T␤4 Ϫ/Y mice did not show any defect in mural cell coverage when compared with T␤4 ϩ/Y littermate controls (Online Figure  VC through E), suggesting that impaired migration of mural cells is unlikely to be responsible for the defective mural cell coverage of T␤4 Ϫ/Y embryos. In addition, mural cells displayed no overtly abnormal levels of proliferation or apoptosis, as measured by phospho-histone H3 or cleaved caspase 3 immunofluorescence staining, respectively, in either T␤4 ϩ/Y or T␤4 Ϫ/Y embryos (Online Figure VIA through F), thus ruling out the possibility that the mural cell defects observed were due to defective mural cell hyperplasia or survival. Blood vessels in mesoderm-derived tissues are thought to recruit mural cells via the in situ differentiation of mesoderm progenitors into mature mural cells. 5 Given that mural cell defects in T␤4 Ϫ/Y embryos are present only in mesodermal tissues, such as the aorta and subdermal vessels and not in tissues that derive their mural cells via migration, such as the postnatal retina, we investigated whether T␤4 acts to induce mesoderm differentiation into a mature mural cell lineage. Initially, we assessed the ability of exogenous T␤4 to stimulate the differentiation of a P19 embryonal carcinoma cell line known as A404, 17 clonally selected for a propensity to differentiate into mural cells. Treatment of A404 mural cell progenitor cells with synthetic T␤4 resulted in an increased number of SM22␣-and SM␣A-positive cells in culture compared with vehicle-treated controls ( Figure 6A , 6B, 6E, and 6F). TGF␤ was used as a positive control in these experiments and resulted in an equivalent increase in the incidence of SM22␣-and SM␣A-positive cells that was further augmented by the combined addition of both T␤4 and TGF␤ ( Figure 6C, 6D, 6G, and 6H ). The phenotypic changes in the A404 cells and coincident expression of the smooth muscle differentiation markers in culture were accompanied by a significant upregulation of mural gene expression, as quantified by qRT-PCR. Markers of both VSMCs such as SM␣A and SM22␣ and pericytes, such as endosialin and desmin, were all significantly upregulated ( Figure 6I) ). These data indicate that T␤4 can act in a paracrine fashion to stimulate mural cell differentiation from mesoderm.
T␤4 Stimulates Mural Cell Differentiation by Enhancing the Activity of TGF␤ Signaling
To gain greater insight into the molecular mechanisms underlying the role of T␤4 in mural cell differentiation, gene expression arrays were carried out on E12.5 T␤4 Ϫ/Y and ϩ/Y embryos and compared with array data from T␤4 ϩ/Y and Ϫ/Y adult hearts to further facilitate the identification of T␤4-dependent gene expression. Metacore software from GeneGo was used to highlight the expression changes of signaling factors in the embryo and adult heart datasets and identify the most likely underlying pathways. Four of the top 5 highlighted pathways included TGF␤ (Table 2) , previously highlighted as a key molecule involved in mural cell differentiation. 17, 18 Thus, we hypothesized that T␤4 may exert its effects on mural cell differentiation by interaction with and/or modulation of the TGF␤ pathway.
Activation of the canonical TGF␤ pathway in mural cells leads to the transcription of stereotypical TGF␤-responsive genes such as plasminogen activator inhibitor-1 (PAI-1), Id-1, and c-myc. 19, 20 Levels of the mRNAs encoding these proteins can be used as a read-out of TGF␤ pathway activity. , which in combination with T␤4 augmented a further significant effect on cell morphology and smooth muscle cell marker expression (D and H; white arrowheads in D highlight differentiated cells). The addition of T␤4 alone or in combination with TGF␤ resulted in a significant upregulation of a wide panel of mural cell markers as measured by qRT-PCR (I; nϭ8 per treatment group) and also significantly enhanced the expression of the TGF␤ target genes PAI-1, Id-1, and c-myc, an effect that was blocked by the addition of T␤4-neutralizing antibody (J). Coculture of A404 cells with HUVECs (PECAMϩ) induced differentiation of the progenitors as indicated by a change in cell morphology and expression of SM␣A (K and L). A404 differentiation was inhibited by the addition of T␤4-neutralizing antibody (M and N), suggesting that T␤4 is a key paracrine factor secreted from HUVECs to regulate mural cell differentiation. HUVEC Treatment of A404 cells with T␤4 led to significant upregulation of these TGF␤ target genes, comparable to that induced by TGF␤ alone, as measured by qRT-PCR, and, moreover, combined T␤4 and TGF␤ acted to further significantly increase expression of all 3 target genes, indicating that T␤4 can enhance TGF␤ signaling in these cells ( Figure 6J ). We next examined cocultures of A404 progenitors with HUVECs, plus or minus T␤4 neutralizing antibody. Importantly, T␤4 antibody alone had no effect on A404 differentiation per se as confirmed by addition to A404 cultures followed by qRT-PCR ( Figure 6I and 6J ; black hatched bars). HUVECs express T␤4 at high levels, 21 and in the control setting, HUVEC coculture brought about differentiation of the A404 cells, as indicated by changes in cell morphology (adoption of a more elongated and differentiated phenotype) and expression of SM␣A ( Figure 6K and 6L) . However, the addition of T␤4 antibody significantly blocked the visible differentiation of A404 cells in culture ( Figure 6M and 6N) and significantly reduced the expression of both mural cell markers ( Figure 6O ) and the TGF␤ targets PAI-1, Id-1 and c-myc ( Figure 6P ).
Binding of TGF␤ ligands to their cognate receptors leads to phosphorylation of Smad adaptor proteins. 22 Treatment of A404 cells with T␤4 alone resulted in increased levels of phospho-Smad2, to an equivalent level to TGF␤ alone ( Figure 7A ). Most notably, T␤4 in combination with TGF␤ was able to induce higher levels of Smad2 phosphorylation than TGF␤ treatment alone ( Figure 7A ). To investigate whether T␤4 might be required for TGF␤ signaling via Smad2 in vascular development, we assessed phospho-Smad2 levels in global T␤4 Ϫ/Y embryos and observed a significant downregulation of phospho-Smad2 in both mildly and severely affected Ϫ/Y mutants compared with littermate (ϩ/Y) controls ( Figure 7B) .
These data collectively suggest that endothelial T␤4, acting in a paracrine fashion, regulates mural cell differentiation to VSMCs via synergistic activation of the TGF␤ signaling pathway.
Inhibition of the TGF␤ Pathway Correlates With the Penetrance of Hemorrhage in T␤4-Null Aortas and Alterations in Downstream Signaling
To further determine whether TGF␤ signaling was impaired with loss of T␤4 in vivo, we examined aortas at E10.5 from T␤4-null mutants, with or without evidence of vascular The top 200 hundred upregulated and downregulated genes identified by affymetrix exon array between T␤4 ϩ/Y and T␤4 Ϫ/Y E12.5 embryos and T␤4 ϩ/Y and T␤4 Ϫ/Y adult hearts were analyzed using Genego Metacore software http://www.genego.com/ metacore.php. Reverse pathway analysis based on altered gene expression levels and comparison to a systems biology database identified potential disrupted signaling pathways in the T␤4 Ϫ/Y embryos. Four of the top 5 potentially disrupted pathways involved TGF␤ as a major signaling node. Displayed are the nodes present in the top 5 ranked putative pathways alongside levels of differential expression per transcript in the exon arrays.
hemorrhage, compared with wild-type littermates, by immunostaining for SM␣A and phospho-Smad2 (pSmad2) with Image J quantification ( Figure 8A through 8F) . Consistent with the previous NG2 and SM-MHC analyses (Figure 3) , the VSMC layer was significantly reduced in the mutants with hemorrhaging as compared with those with a mild, nonhemorrhagic phenotype and wild-type littermates (Figure 8A through 8D ). This was accompanied by a significant reduction in both the percentage of mural cells positive for pSmad2 and intensity of pSmad2 staining within the aortic wall ( Figure 8E and 8F) . Interestingly, in the mildly affected T␤4-null mutants the percentage of pSmad2-positive cells was significantly increased as compared with the wild-type controls, suggesting some form of overcompensation to maintain the integrity of the aorta wall ( Figure 8E ). To provide further evidence for the ability of T␤4 to activate the TGF␤/Smad pathway, 10T1/2 cells were transfected with a construct encoding firefly luciferase under the control of a Smad responsive element (SRE). Treatment with T␤4 stimulated SRE-dependent reporter activity to a level significantly higher than that of PBS alone and in combination with TGF␤ stimulated significantly higher activity than TGF␤ treatment alone ( Figure 8G ). Consistent with the in vivo pSmad2 data ( Figure 8A through 8F) expression levels of the TGF␤ responsive genes, PAI-1, Id-1, and c-myc were found to be significantly downregulated in E10.5 T␤4 Ϫ/Y embryos compared with somite-matched T␤4 ϩ/Y controls, as additional proof of defective TGF␤ downstream signaling in vivo after loss of T␤4 ( Figure 8H ).
Discussion
This study reveals that in the absence of endothelial T␤4, the secreted signals from the developing endothelium are no longer adequate to induce differentiation of mesodermal progenitor cells to a mural cell phenotype. At a molecular level, this is due to a deficiency in TGF␤ signaling in the mesodermal progenitor cell population and manifests as impaired mural investiture of the developing systemic vasculature in general and the aorta in particular.
We initially mapped the vascular expression of T␤4 predominantly to the developing endothelium. Global knockout of the T␤4 gene in the developing embryo resulted in a proportion of the resulting E10.5 embryos exhibiting pericardial and coelomic cavity hemorrhage. An explanation for this hemorrhagic phenotype was evident through the observation that dorsal aortas in the T␤4-null mice had reduced mural cell coverage in comparison to control littermates. The phenotype of the global knockout embryos was incompletely penetrant and subject to apparent compensation, such that we observed mutant embryos with both intact vasculature and those with a more severe hemorrhagic phenotype. This was reflected in survival rates across distinct stages in development. Lethality occurred both between E10.5 and E14,5 due to hemorrhaging, and beyond E14.5 up to birth whereby global knockout embryos revealed epicardium-derived coronary vascular de- fects, as previously described after shRNA knockdown of T␤4 in the developing myocardium. 9 Interestingly, survival of T␤4 global knockout mice was in stark contrast to the lethality observed between E14.5 to 16.5 after optimal cardiac-specific knockdown. 9 The previous RNAi model revealed a direct correlation between the severity of defective coronary angiogenesis and level of T␤4 protein, and, moreover, reciprocal T␤4 gain of function precisely restored the epicardial-derived vascular cell migration and differentiation disrupted by shRNA-induced loss of function. Thus we excluded, to all intents and purposes, the possibility of off-target effects, as can be associated with shRNA gene silencing, increasing the incidence of embryonic lethality. Rather, the differences between our global knockout and knockdown model are probably attributed to the fact that RNAi targeting in vivo, when sufficiently optimal to abrogate expression of the target gene, can result in a more severe phenotype than a corresponding global-null. Genetic ablation via homologous recombination through the germline, leading to complete loss of function from the outset in development, may be partially compensated for by functional orthologues, whereas RNAi-mediated efficient knockdown, occurring rapidly and at a defined developmental stage, may not be permissive for compensation. 23 In a recent study, T␤4 was described as dispensable for murine cardiac development and function after both global and cardiac-specific knockout. 24 This contrasts with our findings describing partially penetrant vascular phenotypes after complete loss of T␤4; however, we acknowledge that over successive generations the incidence of embryonic lethality decreased from 40% at the outset of the study (60% survival) to a current level of 20% loss in utero (80% survival) due to presumptive modifier effects. That said, there is a clear vascular phenotype in our T␤4-null background both within the developing systemic and coronary vasculature, and therefore differences between our findings herein and that previously described may reflect allelic variation in the targeting strategy or genetic background-dependent events. It should be noted, however, that in the earlier study, the T␤4 knockout aortas had an apparent reduction in ␣-SMAϩ cell coverage within the vessel wall relative to wild-type controls at E14.5 24 ; while not commented at the time, this finding is consistent with our phenotype as described. Figure 8 . TGF␤ signaling is reduced in T␤4-null embryonic aortas and correlates with the severity of hemorrhagic phenotype. Immunostaining for SM␣A and pSmad2 revealed a loss of smooth muscle cell coverage and corresponding reduced TGF␤ signaling in the aortas of severely affected (KO severe) T␤4 Ϫ/Y embryos at E10.5, which exhibited hemorrhaging compared with both ϩ/Y wildtype and T␤4 Ϫ/Y mutants that had a mild phenotype and intact vasculature (KO mild; A through C). Inset in A highlights punctate pSmad2 staining in the nuclei of a smooth muscle cell and underlying endothelial cell within the aorta wall; white arrowheads (A through C) highlight pSmad2positive nuclei. The reduced mural cell coverage and pSmad2 signal was quantified using Image J to record relative fluorescence of SM␣A. The percentage of pSmad2-positive nuclei and pSmad2 fluorescence in images across the 3 categories were recorded at the same filter and light intensity settings and exposure time (D and E). SM␣A fluorescence was significantly reduced in the severe KO mutant aortas compared with both wild-type and mild mutants (D). The percentage of pSmad2-positive nuclei within the mural cell layer was significantly reduced in the severe mutants, whereas in the mild mutants, the percentage was significantly increased compared with wild-type indicative of a compensatory response to upregulate TGF␤ signaling and maintain the integrity of the aorta wall (E). pSmad2 fluorescence was significantly reduced in the severe KO compared with both wild-type and compensated mutants (F). To confirm a synergistic effect of T␤4 on TGF␤ signaling, treatment of 10T1/2 cells transfected with a luciferase reporter construct under control of a Smad-responsive element (SRE) with 100 ng/mL T␤4 showed a significant increase in luciferase activity compared with treatment with PBS. Treatment with 2 ng/mL TGF␤ activated luciferase expression higher than T␤4 alone, whereas a combination of both T␤4 and TGF␤ at the same doses revealed a significant additive effect on luciferase activity (G; nϭ6 per treatment group). TGF␤-responsive transcription factors PAI-1, Id-1, and c-myc were significantly decreased in T␤4 Ϫ/Y embryos in comparison to somite matched T␤4 ϩ/Y controls as measured by qRT-PCR (H; nϭ8 embryo pairs run in triplicate per qRT-PCR run). DA indicates dorsal aorta. Scale bar in B as applies to A through C, 10 m. Statistics: *PՅ0.05, **PՅ0.01, ***PՅ0.001; Student t test (D and E); 2-tailed Mann-Whitney U test (G and H). Error bars represent standard error of the mean.
Embryonic mural cell defects generally arise as a result of perturbation of one or more of the proliferation, survival, migration, or differentiation of mural cells. 3 A proliferation defect was ruled out on the basis of examination of E10.5 dorsal aorta mural cells for the presence of the proliferative marker phospho histone H3 and apoptosis excluded by a lack of cleaved caspase 3 expression. The anatomic location of mural cell defects also provided a clue to the role of T␤4. The mural cell investiture of the postnatal retina is thought to rely on the migration of phenotypically mature mural cells, along a vascular plexus. 2, 5 As no defects were observed in the postnatal retina of T␤4 Ϫ/Y mice, it is unlikely that T␤4 is exerting its effects by reducing the migration of mural cells to their target locations. In contrast, the vascular defects in the T␤4 Ϫ/Y mouse tend to occur in vessels which derive their mural cell coverage from the in situ differentiation of overlying mesoderm, notably the E10.5 dorsal aorta and the E14.5 dermal vasculature. Given that the normal induction of a mural cell layer around the dorsal aorta occurs over a narrow time window in murine development, between E9.5 and E10.5, and that T␤4 Ϫ/Y mice first exhibit mural cell defects at E10.5, we hypothesized that the process of mural cell differentiation is aberrant in T␤4 Ϫ/Y mice. Further insight into the cellular basis of T␤4-induced mural cell differentiation arose from the observation that endothelial cell (EC)specific T␤4 knockdown recapitulated the aortic mural cell defects observed in the global knockout. In this instance, despite overlap in the mural cell phenotype, the embryonic lethality was not as significant as in the global knockout at stages between E10.5 and E14.5, reflecting reduced systemic vessel hemorrhaging due to incomplete knockdown of T␤4. Beyond E14.5, through to birth, the EC knockdown of T␤4 had no effect on the coronary vasculature, the cause of later onset lethality in the global knockout embryos. Importantly, a reduction in mural cell differentiation after EC-specific knockdown in this study was complemented by mural cell differentiation from mesodermal progenitors on T␤4 treatment, further supporting the specificity of the particular shRNA used in the EC targeting, identical to that previously described for the myocardial knockdown and defective coronary vasculature. 9 Thus, T␤4, produced by the developing endothelium, acts in a paracrine fashion to stimulate the differentiation of overlying mesoderm into mature mural cells for vascular support. In support of this, exogenous administration of T␤4 to an in vitro cell model of mural cell differentiation caused the induction of mature mural cell markers and T␤4neutralizing antibody in coculture experiments prevented HUVEC-induced differentiation of A404 mural progenitors. Bioinformatic analysis of gene expression data in the T␤4 Ϫ/Y embryos implicated the TGF␤ pathway as a molecular mediator of the defects observed in the T␤4 Ϫ/Y mice. During embryogenesis, TGF␤ has been identified as one of the central factors in the formation of a normal mural cell component of the vessel wall, 3 and in this study, we implicate TGF␤ signaling as an important modulator of T␤4 function in the developing vasculature. Exogenous T␤4 was observed to upregulate the expression of TGF␤ target genes during T␤4-induced A404 mural cell differentiation. Moreover, T␤4 was able to stimulate the activity of a Smad-responsive transcriptional element in transfected 10T1/2 cells and induce higher levels of phosphorylation of Smad2 when used in combination with TGF␤ than with TGF␤ alone. In vivo expression profiling of E10.5 T␤4 Ϫ/Y embryos revealed a global downregulation of the TGF␤ pathway in the absence of T␤4, and importantly, within the mural cell and VSMC layers of E10.5 T␤4 mutant aortas, we observed correlative changes in TGF␤ signaling via immunostaining for phospho-Smad2 with severity and penetrance of the T␤4-mutant phenotype. In those T␤4 Ϫ/Y embryos whose vasculature appeared phenotypically normal, we observed a compensatory increase in phospho-Smad2 expression, which may underlie the incomplete penetrance of the vascular phenotype after loss of T␤4, whereas in the mutants with reduced mural cells and, accompanying hemorrhage, phospho-Smad2 was reduced in the VSMC layer. The implication of signaling downstream of TGF␤ in this instance is consistent with a recent study which conditionally inactivated TGF␤ type II receptor to reveal an essential role in the VSMC differentiation of the descending aorta such that mutant embryos displayed occasional aneurysms. 25 Figure 9 . Developmental model for the role of T␤4 in the embryonic vasculature. T␤4 is secreted by the developing endothelium to act on mesodermal progenitor cells and stimulate TGF␤ target gene transcription through a cooperational effect on Smad2 phosphorylation with TGF␤ ligand. This results in increased transcription of canonical mural cell genes such as SM␣A, NG2, endosialin, and others, which in turn promotes mural cell differentiation and investiture of the endothelium with a fully formed media wall. In the absence of T␤4, the effect of endothelial secreted TGF␤ is reduced, leading to decreased Smad2 phosphorylation in mesodermal progenitors resulting in lower TGF␤ target gene activation. This causes impaired mural cell differentiation and reduced mural cell recruitment to the developing vessel wall. If mural cell coverage falls below a critical threshold, the vessel loses structural integrity and hemorrhage results.
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We previously observed that in the developing heart, T␤4 acts as a secreted myocardial factor on the migration and differentiation of epicardium-derived progenitor cells to form the smooth muscle layer of the coronary vasculature. 9 More recently, we have also shown that T␤4 is a key transcriptional target of the basic helix-loop-helix transcription factor Hand1 and its downregulation is, in part, responsible for the defects seen in the yolk sac vasculature of Hand1-null mutants. 26 The present study allows us to expand the role of T␤4 acting in these highly stereotyped situations to a more generalized function in vascular development. T␤4 is a significant regulator of VSMC development, functioning as a paracrine signal from myocardial, 9 extra-embryonic mesodermal, 26 and endothelial lineages (herein), in an analogous manner to components of the Notch pathway. 27 Thus, T␤4 occupies a central role in the formation of a functional circulatory system such that absence or perturbation in T␤4 function leads to serious deleterious consequences for the growth and stability of blood vessels.
The significance of T␤4-dependent abnormalities in vascular development is their potential relevance to adult health and disease. Many pathological processes are caused by, or involve, the subversion of normal mural cell development, 28 and an insult that results in depletion of medial VSMCs or a loss of functional VSMCs may be critical for adult aortic stability and vascular function. The model we propose (Figure 9 ) highlights the importance of secreted paracrine factors acting on mural cells and their progenitor populations, specifically in terms of their functional developmental role. Interest in identifying novel candidate molecules that function in these developmental pathways stems from the ability to agonize or antagonize their effects for therapeutic benefit. Thus, our discovery of T␤4 as a secreted endothelial factor, which stimulates mesodermal progenitor differentiation into mural cells, can be seen in the context of not only a critical role in vascular development but highlights T␤4 as a possible mediator of postnatal aortic function.
